Catapult Health Launches Virtual Checkup For Preventive Care

PR Newswire | June 24, 2020

Catapult Health Launches Virtual Checkup For Preventive Care
Catapult Health, a leading provider of onsite and virtual preventive healthcare, today announced a new program for employers offering preventive care checkups to their employees, regardless of location. Catapult Health's new Virtual Checkup brings the clinical preventive care appointment to any location, incorporating a home kit for blood testing, key measurements, medical history, depression and COVID-19 screenings, a virtual consultation with a nurse practitioner, plus a personal health report. As employers address a "next normal" due to COVID-19, they are faced with a larger remote workforce, who may have new or worsening chronic conditions due to delayed wellness visits with their doctors out of concern of the virus. The stress of the pandemic has also negatively impacted mental health. Virtual care is being used by some as an option and there is a high level of interest among employers in expanding their use of virtual care. Employers looking to support employees often have narrow, specialized options designed to address specific issues. Catapult Health offers a comprehensive, clinically-based program that engages and educates participants at the time of appointment, traditionally working with employers for preventive checkups at onsite clinics. In introducing this virtual program, employers now have another option for preventive checkups and can easily include satellite locations, remote employees, and even spouses.

Spotlight

The CEO of health insurer Cigna, David Cordani, says the problem with America's health care system is that most of the money being spent is on intervention after people already are sick. Cordani believes we need to spend more money and resources keeping people healthy in the first place.


Other News

HEALTH TECHNOLOGY

PulsePoint Releases Next Generation Health Media Platform With Advanced Automation And AI

PulsePoint | July 06, 2021

PulsePoint, a technology company revolutionizing health decision-making in real-time, today announced the next generation launch of its digital media buying platform, Life by PulsePoint™. Its enhanced AI and automation simplifies and supercharges the media planning, activation, and optimization processes. Designed for the self-serve programmatic trader, these updates promote efficiencies and surface predictive and in-flight campaign analytics for quick strategic decisioning to yield higher media return on investment. Built upon PulsePoint's extensive data foundation, Genome™, that proactively uses microdata to capture attention when intent is signal...

Read More

HEALTH TECHNOLOGY

Future Health announced today that it has completely digitalised its annual in-person event at ExCeL London

Future Health | March 02, 2021

Future Health has completely rebranded during lockdown, and the flagship face-to-face event Future Health Innovations at ExCeL is now complemented by a global virtual conference series, under the brand UK Health Week. Free for delegates to attend, it is CPD and CME accredited. Participants will be able to connect, meet buyers and partake in cross border purchasing, education and deal making, enabling an increased ROI and profitable encounters with its AI powered networking software. Further Health Weeks are being rolled out around the world over the course of the coming months, and will be territory specific. Dawn Barclay-Ross, Event Director commented: “I think ...

Read More

HEALTH TECHNOLOGY

L2Mtech GmbH Receives CE Mark Approval on 6(SIX) products for Cardiovascular and Endovascular Applications

L2Mtech | February 17, 2021

CE Mark Approval for LimusTrack™, Sirolimus Eluting Coronary Stent System for Cardiovascular Applications. CE Mark Approval for LomiFlow™, Paclitaxel Drug Eluting Balloon for Cardiovascular Applications CE Mark Approval for PearlFlow™, Paclitaxel Drug Elutin Balloon for Endovascular Applications CE Mark Approval for PearlFlow NS™, Self Expandable Nitinol Stent System for Endovascular Applications CE Mark Approval for FlexiTrack 018™, Peripheral Balloon Catheter for Endovascular Applications CE Mark Approval for

Read More

CMS to pay providers via MIPS for participating in COVID-19 drug treatment trials

CMS | April 21, 2020

Clinicians can earn a credit via the Merit-based Incentive Payment System (MIPS) if they participate in a clinical trial and report clinical information on COVID-19, the Trump administration announced late Monday. The Centers for Medicare & Medicaid Services (CMS) said Monday that the goal of the new credit is to provide data that will be vital to making treatments to combat the virus. “The best scientific and medical minds in the world are working night and day to find treatments to combat coronavirus,” CMS Administrator Seema Verma said in a statement Monday. “But without solid data, their efforts are liable to run against a brick wall.”...

Read More

Spotlight

The CEO of health insurer Cigna, David Cordani, says the problem with America's health care system is that most of the money being spent is on intervention after people already are sick. Cordani believes we need to spend more money and resources keeping people healthy in the first place.

Resources

Events